It's time to flip the calendar to a new month, but a new quarter as well, resetting the psychological clock for investors. We're also entering a time of year that's uniquely (though reliably) bullish for biotech stocks … a boost most of them could ... Nasdaq, 1 hour ago
#Biopharma News: #OPKO Health (NASDAQ: $OPK) to Acquire Transition Therapeutics (NASDAQ: $TTHI, TSX: $TTH) for US$60 million
(Investorideas.com Newswire) OPKO Health, Inc. (NASDAQ:OPK) and Transition Therapeutics Inc. (NASDAQ:TTHI, TSX:TTH) announce the signing of a definitive agreement under which OPKO will acquire Transition Therapeutics, a clinical stage biotechnology ...InvestorIdeas.com, 5 hours ago
Savaysa Is Safe And Effective According To Recent Study, But Doctors Still Concerned About Lack Of Antidote To Stop Bleeding
Some Xarelto And Eliquis Lawsuits Accuse Drug Makers Of Failing To Warn That In Event Of Uncontrollable Bleeding There Is No Antidote, Just Like With Savaysa (Posted by Tom Lamb at DrugInjuryWatch.com ) The headline of a recent medical ...Drug Injury Watch, 5 hours ago
Drug major Pfizer Inc today said it will acquire biopharmaceutical firm Anacor Pharmaceuticals for around USD 5.2 billion in an all-cash deal. Pfizer and Anacor Pharmaceuticals have entered into a definitive merger agreement under which Pfizer will acquire ...Deccan Herald, 1 month ago
on your WebpageAdd Widget >Get your members hooked!